Clinical analysis of systemic lupus erythematosus complicated with antiphospholipid syndrome

金莉,马艳,李向培,厉小梅,吴竞生,汪国生,陶金辉,钱龙

DOI: https://doi.org/10.3969/j.issn.1671-2870.2014.03.004

2014-01-01

Abstract:Objective To investigate the occurrence, clinical characteristics and laboratory index of systemic lupus erythematosus(SLE) with secondary antiphospholipid syndrome(APS). Methods One hundred and twenty-nine patients with SLE and APS from Jan 2005 to Jan 2014 were enrolled. Data from patients including clinical manifestations,pregnancy, anti-nuclear antibody and anti-cardiolipin antibody were analyzed retrospectively. Results Among the 129patients,8 patients had primary APS, 41 patients had systemic lupus erythematosus complicated with antiphospholipid syndrome(SLE-APS), 40 patients had SLE only(SLE-APA-), and 40 patients had SLE with abnormally positive APA, yet the diagnosis of APS was not definite(SLE-APA+). For 8 patients with APS, 3 male patients had lower limb deep venous thrombus and micro-artery-thrombosis of hand, and the other 5 female patients had abnormal pregnancy(spontaneous abortion or dead fetus). Two of the 5 female had pulmonary thrombus and spleen/ portal vein embolization. Of the 41cases with SLE-APS, 15cases had lower limb deep venous thrombus, 10 cases had cerebral infarction, and 3 patients had pulmonary thrombus. Serum level of anti-β2-GP-1 was significantly higher in SLE-APS group than that in SLE-APA+and SLE-APA-groups, while platelet count was significantly lower. Conclusions High serum level of anti-β2-GP-1 is seen in patient with SLE complicated with APS, high anti-β2-GP-1 may be an independent risk factor for the development of secondary APS.